4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine

C19H25FN10O — CID 154163449

IUPAC4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine
SMILESCC(C)n1cnc(N(c2nc(N)nc(N3CCOCC3)n2)[C@@H](C)c2ncc(F)cn2)c1
InChIInChI=1S/C19H25FN10O/c1-12(2)29-10-15(24-11-29)30(13(3)16-22-8-14(20)9-23-16)19-26-17(21)25-18(27-19)28-4-6-31-7-5-28/h8-13H,4-7H2,1-3H3,(H2,21,25,26,27)/t13-/m0/s1
InChIKeyYYCWSERPTQUVPK-ZDUSSCGKSA-N
MW428.48 g/mol
LogP1.90
Rot. Bonds6

About 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine

4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine (PubChem CID 154163449) has the molecular formula C19H25FN10O and a molecular weight of 428.48 g/mol. Its IUPAC name is 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine.

Molecular Properties

Compound Name4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine
PubChem CID154163449
Molecular FormulaC19H25FN10O
Molecular Weight428.48 g/mol
Exact Mass428.22
IUPAC Name4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine
SMILESCC(C)n1cnc(N(c2nc(N)nc(N3CCOCC3)n2)[C@@H](C)c2ncc(F)cn2)c1
InChIInChI=1S/C19H25FN10O/c1-12(2)29-10-15(24-11-29)30(13(3)16-22-8-14(20)9-23-16)19-26-17(21)25-18(27-19)28-4-6-31-7-5-28/h8-13H,4-7H2,1-3H3,(H2,21,25,26,27)/t13-/m0/s1
InChIKeyYYCWSERPTQUVPK-ZDUSSCGKSA-N
XLogP1.90
TPSA124.00 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500428.48
LogP ≤ 51.90
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Analyze 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine?
The IUPAC name of 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine (CID 154163449) is 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine.
What is the SMILES notation for 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine?
The canonical SMILES for 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine is CC(C)n1cnc(N(c2nc(N)nc(N3CCOCC3)n2)[C@@H](C)c2ncc(F)cn2)c1.
What is the InChIKey of 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine?
The InChIKey is YYCWSERPTQUVPK-ZDUSSCGKSA-N. The full InChI is InChI=1S/C19H25FN10O/c1-12(2)29-10-15(24-11-29)30(13(3)16-22-8-14(20)9-23-16)19-26-17(21)25-18(27-19)28-4-6-31-7-5-28/h8-13H,4-7H2,1-3H3,(H2,21,25,26,27)/t13-/m0/s1.
What are the key properties of 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine?
4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine has a molecular weight of 428.48 g/mol, XLogP of 1.90, 6 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-6-morpholin-4-yl-4-N-(1-propan-2-ylimidazol-4-yl)-1,3,5-triazine-2,4-diamine is sourced from PubChem (CID 154163449), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).